is glucophage a glp-1 Analogs and DeFronzo's Octet What next when metformin isn't
Description
The study included adults with Type 2 diabetes who were newly prescribed either a GLP-1 receptor agonist or a DPP-4 inhibitor
This guide breaks down every meaningful difference between these two medications
These effects are transient and will diminish as your body adjusts to the medication
Between Q4 2024 and Q1 2025, the share of Medicare patients with comorbid diabetes or obesity and MASLD who started a GLP1 rose from 13% to 19%, compared with only a modest increase from 20% to 22% among commercially insured patients
Source: Novo Nordisk - PR Newswire
